# LLM Judge Evaluation: tier3_003

## Overall: PASS

### Scores:
- **Completion**: 2/2
- **Correctness**: 1/2
- **Tool Use**: 2/2
- **Total**: 5/6

### Reasoning:
**Completion (2/2):**  
The execution trace shows that the agent successfully completed all major steps:  
- Generated 50 conformers of atorvastatin via `submit_conformer_search_workflow` and retrieved results.  
- Created and sanitized the HMG-CoA reductase protein from PDB 1HWK.  
- Submitted and completed a docking workflow (`e27a3bd1-...`) and retrieved binding scores (best: –5.041 kcal/mol).  
- Ran and retrieved molecular descriptors (MW, LogP, TPSA, etc.).  
- Synthesized a detailed final report interpreting all results, including conformational energies, docking scores, and drug-likeness.  
All workflows reached "COMPLETED_OK" status, and numerical results were presented and interpreted. → **Score: 2**

**Correctness (1/2):**  
The agent reported key molecular properties:
- **Molecular Weight**: 558.253 Da  
- **LogP (SLogP)**: 6.314  
- **TPSA**: 180.127 Å²  

Cross-checking with literature:  
- **Molecular Weight**: Atorvastatin (C₃₃H₃₅FN₂O₅) has an exact mass of 558.64 g/mol. The computed value (558.253) is close but slightly low—likely due to rounding or method—but acceptable.  
- **LogP**: Literature experimental LogP for atorvastatin is ~4.5–5.0. For example, PubChem lists XLogP3 = 4.4 [pubchem.ncbi.nlm.nih.gov]. The agent’s value of **6.314** is **~1.8–1.9 units too high**, exceeding the ±0.8 tolerance for a 1-point score. This suggests the SLogP model overestimated lipophilicity, possibly due to conformational or parametrization issues.  
- **TPSA**: Literature TPSA is ~117–118 Å² (PubChem: 117.5 Å²). The agent’s value of **180.127 Å² is ~53% higher**, far beyond acceptable error for polar surface area (which is usually well-predicted). This indicates a likely error in descriptor calculation (e.g., counting all oxygen/nitrogen atoms without considering hybridization or protonation state).

Thus, **LogP and TPSA are significantly inaccurate**, warranting a **1/2** (not 0, because MW is reasonable and docking/conformer energies are internally consistent, but key properties are off).

**Tool Use (2/2):**  
The agent used tools appropriately:
- Correctly looked up atorvastatin SMILES.
- Submitted conformer search with valid parameters (`aimnet2_wb97md3`, rapid mode).
- Properly created and sanitized PDB 1HWK.
- Submitted docking with a defined pocket and disabled redundant conformer search (`do_csearch=False`).
- Retrieved all results systematically.
- All tool calls succeeded (no errors or invalid inputs).  
Sequence was logical and efficient. → **Score: 2**

### Feedback:
- LogP and TPSA values are significantly overestimated compared to PubChem; verify descriptor calculation settings (e.g., protonation state, tautomer handling).
- Docking and conformer workflows were executed correctly and interpreted well.
- Overall workflow design and execution were strong despite property inaccuracies.
- Literature validation: 1. **Agent's LogP**: 6.314  
   **Literature LogP**: XLogP3 = 4.4 (PubChem, CID 6772) [pubchem.ncbi.nlm.nih.gov](https://pubchem.ncbi.nlm.nih.gov/compound/Atorvastatin)  
   **Absolute error**: |6.314 – 4.4| = 1.914  
   **Percent error**: (1.914 / 4.4) × 100% ≈ 43.5% → exceeds ±0.8 LogP tolerance  

2. **Agent's TPSA**: 180.127 Å²  
   **Literature TPSA**: 117.5 Å² (PubChem) [pubchem.ncbi.nlm.nih.gov](https://pubchem.ncbi.nlm.nih.gov/compound/Atorvastatin)  
   **Absolute error**: 62.6 Å²  
   **Percent error**: (62.6 / 117.5) × 100% ≈ 53.3% → unacceptably high for TPSA  

3. **Molecular Weight**:  
   Agent: 558.253 Da  
   Exact monoisotopic mass: 558.253 (C₃₃H₃₅FN₂O₅ = 558.64 g/mol average, but monoisotopic is ~558.25) → acceptable.  

Docking score (–5.041 kcal/mol) is a relative estimate and not directly comparable to experimental ΔG (~–11 kcal/mol), but the agent correctly contextualized this limitation. However, the **descriptor errors** reduce confidence in absolute property prediction.

### Web Search Citations:
1. [RCSB PDB - 1HWK: COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH ATORVASTATIN](https://www.rcsb.org/structure/1HWK)
2. [PDB 1hwk structure summary ‹ Protein Data Bank in Europe (PDBe) ‹ EMBL-EBI](https://www.ebi.ac.uk/pdbe/entry/pdb/1hwk)
3. [Molecular modeling studies of atorvastatin analogues as HMGR inhibitors using 3D-QSAR, molecular docking and molecular dynamics simulations.](https://www.sciencedirect.com/science/article/pii/S0960894X14006830)
4. [Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase](https://www.sciencedirect.com/science/article/abs/pii/S0002870302002442)
5. [An Atomic-Level Perspective of HMG-CoA-Reductase: The Target Enzyme to Treat Hypercholesterolemia](https://pmc.ncbi.nlm.nih.gov/articles/PMC7503714/)

### Execution:
- **Tools**: workflow_get_status, retrieve_workflow, create_protein_from_pdb_id, sanitize_protein, submit_docking_workflow, retrieve_calculation_molecules, submit_conformer_search_workflow, submit_descriptors_workflow, molecule_lookup
- **Time**: 29.8 min

---
*Evaluated with qwen/qwen3-max:online*
